Insights, Delivered Daily.

From breaking market trends to long-term strategy tips, we bring you curated financial content—designed to inform, educate, and empower.
Subscribe to our Newsletter

Daily Market Note (192)

Daily Market Note | Siebert Financial Corporation (“Siebert”) has a full range of brokerage and financial advisory services offered through its operating subsidiaries, affiliates and brands associated with Siebert Financial described below (192)

Daily Market Note

April Showers

April showers. Stocks advanced on Friday as investors looked beyond the horizon and had hope that better days will come. Congress approved the next leg of stimulus and Administration officials hinted of help for oil producers while Georgia became the first state to relax lockdowns - all leaving...
Read More
Daily Market Note

Leak Up, Leak Down

Leak up, leak down. An early day rally for stocks was deflated by a leaked report that showed Remdesivir may not be as effective as hoped. Gilead Sciences, whose stock rose just a few days back on a positive leak, led the US market down to close mixed for the session.
Read More
Daily Market Note

Rising To The Surface

Rising to the surface. Stocks rose yesterday as traders cheered a turn-around in crude oil. Mixed earnings, as expected, added some volatility but the advancing of a new stimulus package on Capitol Hill added fuel to yesterday’s rally.
Read More
Daily Market Note

Future Shock

Future shock. Stocks sold off for a second straight day as investors remained fixated on the rapidly slipping price of crude oil. Earnings are all over the map but most, not all companies agree that these are tough times, indeed.
Read More
Daily Market Note

Slip Sliding Away

Slip sliding away. Stocks slipped yesterday as crude oil supply buildup caused prices to hit historic lows. The price of West Texas Intermediate crude oil fell into negative territory for the first time in the history of the futures contract.
Read More
Daily Market Note

Happiness Is

Happiness is. Stocks rallied on Friday as investors could not contain their inner optimists. Many are hopeful that an end to the national lockdown is near and that promising results from a Remdesivir trial might hold the key to beating the pandemic.
Read More